OraSure memperkirakan pendapatan Q3 sebesar $29,5 juta-$32,5 juta sementara menunda persetujuan FDA InteliQuick CT/NG melampaui tahun 2026 (NASDAQ:OSUR)
· seekingalpha.com
Sorotan panggilan laba Q2 2026 OraSure (OSUR): kenaikan pendapatan/margin kotor, keberhasilan FDA, hambatan CT/NG, dan prospek 2026–27.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...